GSK set to kickstart asthma mAb sector after EU Nucala approval – BioPharma-Reporter.com


BioPharma-Reporter.com

GSK set to kickstart asthma mAb sector after EU Nucala approval
BioPharma-Reporter.com
This decline, coupled with the underperformance of more recently launched drugs – Breo and Anoro Ellipta – saw revenue generated by GSK's asthma franchise fall 10% to £6.1bn in 2014. GSK has not given a forecast for Nucala, but clearly it hopes the

View full post on asthma – Google News

Ministry of Health and private sector team up to tackle asthma – AME Info


AME Info

Ministry of Health and private sector team up to tackle asthma
AME Info
Al Baraha Hospital hosted an Open Day for the public with free sessions on how to manage asthma, in an effort to better support the 13-15% of UAE residents who suffer from the chronic condition. According to studies conducted in the UAE , one in eight
You can control your asthmaKhaleej Times

all 4 news articles »

View full post on asthma – Google News